ABRAZO: An international phase 2 (2-stage, 2-cohort) study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer Meeting Abstract
| Authors: | Turner, N. C.; Balmana, J.; Fasching, P. A.; Hurvitz, S. A.; Rugo, H. S.; Telli, M. L.; Visco, F.; Wardley, A. M.; Yang, X.; Lokker, N. A.; Lounsbury, D. L.; Robson, M. E. |
| Abstract Title: | ABRAZO: An international phase 2 (2-stage, 2-cohort) study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer |
| Meeting Title: | 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 76 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2015 Dec 8-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-02-15 |
| Language: | English |
| ACCESSION: | WOS:000375622402033 |
| DOI: | 10.1158/1538-7445.sabcs15-ot1-03-17 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OT1-03-17 -- Source: Wos |
